{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-184752","form_type":"8-K","ticker":"COYA","cik":"0001835022","company_name":"Coya Therapeutics, Inc.","filed_at":"2023-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.593391+00:00","generated_at":"2026-06-13T10:39:50.539096+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Coya Therapeutics: Dr. Adrian Hepner resigns as President/CMO, replaced by Dr. Fred Grossman","bullets":["Dr. Fred Grossman appointed President and CMO effective July 17, 2023, succeeding Dr. Adrian Hepner who resigned.","Base salary $450,000/year; annual bonus target 40% of base salary based on company-set objectives.","Two option grants each for 74,069 shares (first on start date, second Jan 2024); 24,689 shares vest after 1 year, remainder over 24 months.","Employment agreement initial term of 2 years, auto-renews annually unless either party gives 30-day notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-184752","json":"https://secwatch.observer/filing/0001193125-23-184752.json","markdown":"https://secwatch.observer/filing/0001193125-23-184752.md","text":"https://secwatch.observer/filing/0001193125-23-184752.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835022/000119312523184752/0001193125-23-184752-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835022/000119312523184752/d530395d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T10:39:50.539096+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"86a6802a2b","claim":"Dr. Fred Grossman was appointed as President and Chief Medical Officer at Coya Therapeutics, Inc..","evidence_excerpt":"On July 3, 2023, the Company appointed Dr. Fred Grossman President and Chief Medical Officer, effective July 17, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312523184752/0001193125-23-184752-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Medical Officer"}],"fact_type":"executive_change"},{"claim_id":"bcde235a34","claim":"Dr. Adrian Hepner resigned as President and Chief Medical Officer at Coya Therapeutics, Inc..","evidence_excerpt":"Dr. Adrian Hepner, the current President and Chief Medical Officer of Coya Therapeutics, Inc. (the “Company”), has informed the Company that he will resign from his position effective July 17, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312523184752/0001193125-23-184752-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}